nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abstract reviewers
|
|
|
1999 |
18 |
1 |
p. 3-5 3 p. |
artikel |
2 |
A comparative study of the celsior and the University of Wisconsin solution based upon 12-hr preservation followed by transplantation in canine models
|
|
|
1999 |
18 |
1 |
p. 39- 1 p. |
artikel |
3 |
Acute native lung hyperinflation (ANLH) is not associated with poor outcome after single lung transplant (SLT) for emphysema
|
Weill, D. |
|
1999 |
18 |
1 |
p. 55- 1 p. |
artikel |
4 |
Acute rejection of cardiac allografts deficient in ICAM-1 and P-selectin
|
|
|
1999 |
18 |
1 |
p. 61- 1 p. |
artikel |
5 |
Alterations of the coronary microcirculation by soluble adhesion molecules P-selectin and ICAM-1 after cardiac transplantation in humans
|
Wildhirt, S.M. |
|
1999 |
18 |
1 |
p. 64-65 2 p. |
artikel |
6 |
Altered myocardial and endothelial expression of cyclooxygenase-2 after prolonged mechanical support in patients with severe idiopathic dilated cardiomyopathy
|
|
|
1999 |
18 |
1 |
p. 54- 1 p. |
artikel |
7 |
Analysis of risk factors for chronic lung rejection from a twelve-center, multinational database
|
|
|
1999 |
18 |
1 |
p. 59- 1 p. |
artikel |
8 |
A nation-wide list would cause major redistribution of cadaveric lungs
|
Ely, E.W. |
|
1999 |
18 |
1 |
p. 55-56 2 p. |
artikel |
9 |
A novel approach to test immunosuppressive drugs in heterotopically transplanted lung fragments in rats
|
Ikonen, T.S. |
|
1999 |
18 |
1 |
p. 73- 1 p. |
artikel |
10 |
A novel cell culture model for aerobic, hypothermic lung preservation for transplantation
|
Cardella, J.A. |
|
1999 |
18 |
1 |
p. 88- 1 p. |
artikel |
11 |
Anti-CD3: F(AB′)2-idarubicin conjugates prolong mouse cardiac allografts
|
Mottram, P.L. |
|
1999 |
18 |
1 |
p. 94- 1 p. |
artikel |
12 |
Antilymphocyte globulin (ALG) vs. placebo in immunosuppression in lung transplant
|
|
|
1999 |
18 |
1 |
p. 46- 1 p. |
artikel |
13 |
Apoptosis induced by ischemia and reperfusion in experimental lung transplantation
|
Stammberger, U. |
|
1999 |
18 |
1 |
p. 79- 1 p. |
artikel |
14 |
Apoptosis in human cardiac allografts with transplant coronary artery disease
|
|
|
1999 |
18 |
1 |
p. 90- 1 p. |
artikel |
15 |
Apoptosis in rat cardiac allograft is predominantly associated with cells of the immune response
|
|
|
1999 |
18 |
1 |
p. 40- 1 p. |
artikel |
16 |
A post mortem audit of deaths occurring beyond 30 days following heart-lung transplantation
|
Bardsley, V. |
|
1999 |
18 |
1 |
p. 41- 1 p. |
artikel |
17 |
A prospective study of haemostatic changes after implantation of the NOVACOR LVAS
|
|
|
1999 |
18 |
1 |
p. 43- 1 p. |
artikel |
18 |
Assessment of health related quality of life in pulmonary transplantation: Application of a simple generic tool
|
Anyanwu, A.C. |
|
1999 |
18 |
1 |
p. 51- 1 p. |
artikel |
19 |
Assessment of murine bone marrow transplant chimeras
|
|
|
1999 |
18 |
1 |
p. 88- 1 p. |
artikel |
20 |
Basiliximab (αIL2R Mab) induction therapy combined with subtherapeutic doses of neoral and SDZ RAD successfully prevents allograft rejection in a nonhuman primate lung transplant model
|
Hausen, B. |
|
1999 |
18 |
1 |
p. 73- 1 p. |
artikel |
21 |
8-BR-cyclic GMP given during reperfusion improves posttransplant lung edema and free radical injury
|
Hillinger, S. |
|
1999 |
18 |
1 |
p. 74- 1 p. |
artikel |
22 |
Bridge-to-transplant (BTT) experience with the Novacor left ventricular assist system (LVAS): Results of a multicenter US study
|
|
|
1999 |
18 |
1 |
p. 63- 1 p. |
artikel |
23 |
Cardiac transplant outcome between patients supported on a left ventricular assist device versus intravenous inotropic therapy
|
|
|
1999 |
18 |
1 |
p. 37- 1 p. |
artikel |
24 |
CD4 T cell mediated rejection of cardiac allografts is FAS/FASL sensitive
|
Pietra, B.A. |
|
1999 |
18 |
1 |
p. 48- 1 p. |
artikel |
25 |
Characterization of the skeletal muscle (SM) mitochondrial respiration in severe chronic heart failure (CHF) and its relations to the ventricular oxidative capacity
|
|
|
1999 |
18 |
1 |
p. 71- 1 p. |
artikel |
26 |
Clinical benefit of neoral dose monitoring with cyclosporine 2-hour peak levels compared to trough levels in stable heart transplant patients
|
Cantarovich, M. |
|
1999 |
18 |
1 |
p. 78- 1 p. |
artikel |
27 |
CMVIG favorably affects long-term outcome after heart, heart-lung and lung transplantation
|
|
|
1999 |
18 |
1 |
p. 81- 1 p. |
artikel |
28 |
Comparison of euro collins®- and low potassium dextran (perfadex®) -solution in clinical lung preservation
|
Mu¨ller, C. |
|
1999 |
18 |
1 |
p. 40- 1 p. |
artikel |
29 |
Comparison of long-term effects between tacrolimus and cyclosporine based immunosuppression after HTx
|
|
|
1999 |
18 |
1 |
p. 78- 1 p. |
artikel |
30 |
Competitive RT-PCR for granzyme-B, IL-15 and rantes for molecular diagnosis of lung allograft rejection
|
Zeevi, A. |
|
1999 |
18 |
1 |
p. 81-82 2 p. |
artikel |
31 |
Comprehensive concept to support right ventricular function following left ventricular assist device implantation
|
Wagner, F. |
|
1999 |
18 |
1 |
p. 89- 1 p. |
artikel |
32 |
Continuing medical education information
|
|
|
1999 |
18 |
1 |
p. 6- 1 p. |
artikel |
33 |
Cooperative procurement for lung transplantation improves organ utilization without increasing complications
|
|
|
1999 |
18 |
1 |
p. 86-87 2 p. |
artikel |
34 |
Coronary arteries of human cardiac allograts with transplant coronary artery disease contain oligoclonal populations of T lymphocytes
|
|
|
1999 |
18 |
1 |
p. 60- 1 p. |
artikel |
35 |
Coronary vasomotor response to the selective B1 kinin receptor agonist des-arg9-bradykinin in transplant patients
|
|
|
1999 |
18 |
1 |
p. 64- 1 p. |
artikel |
36 |
Criteria for selecting type of bridge to heart transplantation: The univertity of arizona experience
|
|
|
1999 |
18 |
1 |
p. 89- 1 p. |
artikel |
37 |
Cyclic AMP stimulation protects a porcine pulmonary xenograft from hyperacute rejection
|
|
|
1999 |
18 |
1 |
p. 65- 1 p. |
artikel |
38 |
Cytokine transcripts in coronary arteries and coronary artery-derived T-cell lines from patients with chronic rejection
|
|
|
1999 |
18 |
1 |
p. 41- 1 p. |
artikel |
39 |
Cytomegalovirus immune globulin (CMVIG) in combination with gancyclovir provides cost-effective prophylaxis of CMV after lung transplantation (LTX)
|
|
|
1999 |
18 |
1 |
p. 81- 1 p. |
artikel |
40 |
Death after heart transplantation in children: Who dies when and why
|
|
|
1999 |
18 |
1 |
p. 69-70 2 p. |
artikel |
41 |
Decreased survival associated with size mis-matching in lung transplantation
|
|
|
1999 |
18 |
1 |
p. 60- 1 p. |
artikel |
42 |
Development and spectrum of PTLD in 691 cardiac transplant (Htx) recipients receiving induction therapy
|
Mallinger, R. |
|
1999 |
18 |
1 |
p. 77- 1 p. |
artikel |
43 |
Development of a simple risk model for predciting survival after adult orthotopic heart transplantation
|
Anyanwu, A.C. |
|
1999 |
18 |
1 |
p. 37-38 2 p. |
artikel |
44 |
Development of post lung transplant obliterative bronchiolitis is characterized by increased exhaled nitric oxide, upregulation of iNOS and downregulation of cNOS
|
|
|
1999 |
18 |
1 |
p. 51- 1 p. |
artikel |
45 |
Diagnostic value of structured interviews in assessing noncompliance with immunosuppressive therapy in heart transplant recipients
|
De Geest, S. |
|
1999 |
18 |
1 |
p. 91- 1 p. |
artikel |
46 |
Differences in rejection of rat heart transplants are determined by passenger leukocyte genotype
|
|
|
1999 |
18 |
1 |
p. 68- 1 p. |
artikel |
47 |
Differential effects of cellular cardiomyoplasty on systolic and diastolic performance in cryoinjured rabbit myocardium
|
|
|
1999 |
18 |
1 |
p. 43- 1 p. |
artikel |
48 |
Differential time scale of fluid and solute permeability following hypothermic lung preservation
|
Rooney, S.J. |
|
1999 |
18 |
1 |
p. 73- 1 p. |
artikel |
49 |
Differentiation of human cytomegalovirus (CMV) glycoprotein B and glycoprotein H types by restriction fragment length polymorphism — association of glycoprotein types with CMV disease in heart, heart-lung and lung transplant recipients
|
|
|
1999 |
18 |
1 |
p. 82- 1 p. |
artikel |
50 |
Does cardiac transplantation affect gynecologic and reproductive outcomes?
|
|
|
1999 |
18 |
1 |
p. 58-59 2 p. |
artikel |
51 |
Does initial photopheresis have an impact on the development of graft atherosclerosis after cardiac transplantation — a 6-year follow-up
|
Kur, F. |
|
1999 |
18 |
1 |
p. 93- 1 p. |
artikel |
52 |
Does LVAD bridging-to-transplantation increase graft vasculopathy?
|
Kaplon, R.J. |
|
1999 |
18 |
1 |
p. 63- 1 p. |
artikel |
53 |
Does time to harvest determine outcome in heart transplantation with older allografts?
|
|
|
1999 |
18 |
1 |
p. 39- 1 p. |
artikel |
54 |
Domino heart transplantation: 10 years experience
|
Ongcharit, P. |
|
1999 |
18 |
1 |
p. 37- 1 p. |
artikel |
55 |
Donor and recipient contributions of ICA-1 and P-selectin in parenchymal rejection and graft arteriosclerosis: Insights from double knockout mice
|
|
|
1999 |
18 |
1 |
p. 61- 1 p. |
artikel |
56 |
Donor pre-treatment with inhaled nitric oxide attenuates acute lung injury following single lung transplantation
|
Sudarshan, C.D. |
|
1999 |
18 |
1 |
p. 78- 1 p. |
artikel |
57 |
Donor-specific high avidity cytotoxic T-lymphocytes induced by implantation of cryopreserved human cardiac valves
|
|
|
1999 |
18 |
1 |
p. 53- 1 p. |
artikel |
58 |
Donor specific spleen cells mediate allograft survival by a different mechanism than bone marrow
|
|
|
1999 |
18 |
1 |
p. 69- 1 p. |
artikel |
59 |
Dose and time relationship of cyclosporine on chronic graft vascular disease after transplantation in a rat cardiac isograft model
|
Teranishi, K. |
|
1999 |
18 |
1 |
p. 73- 1 p. |
artikel |
60 |
Dynamic aortomyoplasty with latissimus dorsi. Clinical follow-up
|
|
|
1999 |
18 |
1 |
p. 42-43 2 p. |
artikel |
61 |
Early graft dysfunction in pediatric lung transplant recipients
|
|
|
1999 |
18 |
1 |
p. 82-83 2 p. |
artikel |
62 |
Early mediators of lung ischaemia-reperfusion injury
|
Onwu, N. |
|
1999 |
18 |
1 |
p. 74- 1 p. |
artikel |
63 |
Editorial Board
|
|
|
1999 |
18 |
1 |
p. A7- 1 p. |
artikel |
64 |
Education and the transplanted child
|
|
|
1999 |
18 |
1 |
p. 57- 1 p. |
artikel |
65 |
Effective treatment of lymphoproliferative disease following lung transplantation using a monoclonal anti-CD20 B-cell antibody
|
|
|
1999 |
18 |
1 |
p. 84-85 2 p. |
artikel |
66 |
Effect of donor age on young and older lung transplant recipients
|
|
|
1999 |
18 |
1 |
p. 85- 1 p. |
artikel |
67 |
Effect of histocompatibility, sensitization and other risk factors on the outcome of 14,535 cardiac transplants (TNX) reported to the unos scientific registry
|
|
|
1999 |
18 |
1 |
p. 38-39 2 p. |
artikel |
68 |
Effect of soluble complement receptor type 1 (sCR1) on experimental obliterative bronchiolitis (OB)
|
Kallio, E.A. |
|
1999 |
18 |
1 |
p. 52-53 2 p. |
artikel |
69 |
Effects of celsior preservation solution on myocardial performance and coronary vasomotor function after 2 h of global ischemia in isolated rat hearts
|
Wildhirt, S.M. |
|
1999 |
18 |
1 |
p. 40- 1 p. |
artikel |
70 |
Effects of endothelin A and B receptor antagonists on myocardial and endothelial injury during reperfusion by after heart transplantation
|
|
|
1999 |
18 |
1 |
p. 54- 1 p. |
artikel |
71 |
Effects of MHC class II antigens on the development of cardiac allograft vasculopathy in miniature swine
|
Mawulawde, K. |
|
1999 |
18 |
1 |
p. 53- 1 p. |
artikel |
72 |
Effects of oral ganciclovir on the prevention of cytomegalovirus infection in lung transplant recipients
|
|
|
1999 |
18 |
1 |
p. 85- 1 p. |
artikel |
73 |
Effects of throm☐ane synthase inhibition on hyperacute rejection of lungs (HALR) transgenic for human decay accelerating factor (hDAF)
|
|
|
1999 |
18 |
1 |
p. 54- 1 p. |
artikel |
74 |
Efficacy and safety of sildenafil citrate (VIAGRA) in male heart transplant patients
|
|
|
1999 |
18 |
1 |
p. 58- 1 p. |
artikel |
75 |
Efficacy of donor specific bone marrow in reducing frequency of rejection following heart transplantation
|
McGurl, P.A. |
|
1999 |
18 |
1 |
p. 93- 1 p. |
artikel |
76 |
Epithelial re-growth prevents luminal occlusion in orthotopic tracheal allografts despite acute rejection and proliferation of α-actin positive cells
|
Ikonen, T.S. |
|
1999 |
18 |
1 |
p. 60- 1 p. |
artikel |
77 |
Evaluation of a mentorship programme for heart transplant patients
|
Pennington, J.J. |
|
1999 |
18 |
1 |
p. 91- 1 p. |
artikel |
78 |
Evaluation of circulating epstein-barr virus (EBV) viral load in pediatric thoracic recipients: Implications for diagnosis of posttransplant lymphoproliferative disorders (PTLD)
|
|
|
1999 |
18 |
1 |
p. 83- 1 p. |
artikel |
79 |
Evaluation of regional wall motion abnormalities and ventricular function in pediatric heart transplant patients using dobutamine stress echocardiography
|
|
|
1999 |
18 |
1 |
p. 84- 1 p. |
artikel |
80 |
Factors affecting outcome in patients “Too well” for heart transplantation at initial assessment
|
|
|
1999 |
18 |
1 |
p. 46- 1 p. |
artikel |
81 |
Failure to wean from parenteral inotropes: A strong predictor for early mortality among patients with end stage heart disease
|
|
|
1999 |
18 |
1 |
p. 47-48 2 p. |
artikel |
82 |
Famciclovir treatment of chronic hepatitis B in heart transplant recipients
|
|
|
1999 |
18 |
1 |
p. 81- 1 p. |
artikel |
83 |
Feasibility of a pumpless extracorporeal respiratory assist device
|
|
|
1999 |
18 |
1 |
p. 41-42 2 p. |
artikel |
84 |
Five-year follow-up of a randomized trial of pravastatin in heart transplant patients
|
|
|
1999 |
18 |
1 |
p. 71- 1 p. |
artikel |
85 |
Five years of living lobar donation for bilateral lung transplantation: Long term results in 137 donors
|
|
|
1999 |
18 |
1 |
p. 54- 1 p. |
artikel |
86 |
Five years results of a prospective randomized study comparing a rabbit ATG versus a monoclonal anti-CD25 antibody in de novo cardiac transplant recipients
|
|
|
1999 |
18 |
1 |
p. 94- 1 p. |
artikel |
87 |
Functional responses of anti-CD25 blocked T-cells during cardiac rejection
|
Baan, C.C. |
|
1999 |
18 |
1 |
p. 69- 1 p. |
artikel |
88 |
Ganciclovir and rat cytomegalovirus (RCMV) antisera prophylaxis prevent RCMV infection-enhanced experimental obliterative bronchiolitis (OB) in the rat
|
Tikkanen, J.M. |
|
1999 |
18 |
1 |
p. 62- 1 p. |
artikel |
89 |
Gastroesophageal reflux is an important cause of allograft dysfunction in lung transplant recipients
|
|
|
1999 |
18 |
1 |
p. 51- 1 p. |
artikel |
90 |
Gender mismatch is not associated with reduced survival after heart transplantation
|
|
|
1999 |
18 |
1 |
p. 44- 1 p. |
artikel |
91 |
Gene therapy with soluble FAS decreases AGA in a rat aortic allograft model
|
Wang, Tao |
|
1999 |
18 |
1 |
p. 48-49 2 p. |
artikel |
92 |
Genetic polymorphism of transforming growth factor-β (codon 25) and development of cardiac allograft vascular disease
|
Pethig, K. |
|
1999 |
18 |
1 |
p. 52- 1 p. |
artikel |
93 |
Gene transfection of donor lungs prior to organ procurement increases transgene levels at reperfusion and following transplantation
|
Cassivi, S.D. |
|
1999 |
18 |
1 |
p. 88-89 2 p. |
artikel |
94 |
Heart and lung transplantation from poisoned braindead donors: A 10-year United Kingdom experience
|
Tsui, S.S.L. |
|
1999 |
18 |
1 |
p. 78-79 2 p. |
artikel |
95 |
Hemodynamic compromising rejection is associated with increased incidence of transplant coronary artery disease in cardiac transplant recipients
|
|
|
1999 |
18 |
1 |
p. 50- 1 p. |
artikel |
96 |
Hemodynamic guided inotropic tailoring does not appear to impact long term survival among patients requiring chronic home inotropic therapy
|
|
|
1999 |
18 |
1 |
p. 43- 1 p. |
artikel |
97 |
Hemoglobin A1C predicts of transplant coronary artery disease incidence and severity
|
|
|
1999 |
18 |
1 |
p. 50- 1 p. |
artikel |
98 |
Hepatitis C virus (HCV) positive donor hearts: Impact on morbidity and mortality
|
|
|
1999 |
18 |
1 |
p. 39- 1 p. |
artikel |
99 |
Heterogeneity and reversal of bronchiolitis obliterans syndrome
|
|
|
1999 |
18 |
1 |
p. 59-60 2 p. |
artikel |
100 |
High dose brachytherapy to prevent recurrent benign hyperplasia in lung transplant bronchi; theoretical and clinical applications
|
Sonnett, J.R. |
|
1999 |
18 |
1 |
p. 84- 1 p. |
artikel |
101 |
High frequency of intragraft IFN-γ producing CD8+ T cells is predictive of lung allograft rejection
|
|
|
1999 |
18 |
1 |
p. 82- 1 p. |
artikel |
102 |
Histopathology of resected myocardium is correlated with survival after partial left ventriculectomy - a clue to indication for PLV versus transplantation
|
Kawaguchi, A.T. |
|
1999 |
18 |
1 |
p. 67- 1 p. |
artikel |
103 |
HLA class II matching: Significant impact on long term outcome of lung transplantation
|
|
|
1999 |
18 |
1 |
p. 85- 1 p. |
artikel |
104 |
Human lung preservation can be extended beyond eight hours using UW solution
|
|
|
1999 |
18 |
1 |
p. 87- 1 p. |
artikel |
105 |
Hypersensitivity eosinophilia: A unique cause of cardiac decompensation in inotropic dependent heart failure?
|
|
|
1999 |
18 |
1 |
p. 43- 1 p. |
artikel |
106 |
Hypertension during support with ventricular assist devices: Incidence, risk factors and management
|
|
|
1999 |
18 |
1 |
p. 58- 1 p. |
artikel |
107 |
IGM to IGG anti-HLA class II antibody switching in cardiac transplant recipients reflects T cell responses to donor HLA-DR peptides and is associated with increased risk of cellular rejection and coronary artery disease
|
|
|
1999 |
18 |
1 |
p. 80- 1 p. |
artikel |
108 |
IL-6 and IFN-γ expression parallels recovery of the epithelium in a heterotopic rat model of allograft rejection
|
Wan, B. |
|
1999 |
18 |
1 |
p. 90- 1 p. |
artikel |
109 |
Immunoglobulin adsorption as effective treatment of severe dilated cardiomyopathy
|
Mu¨ller, J. |
|
1999 |
18 |
1 |
p. 70-71 2 p. |
artikel |
110 |
Immunologic assessment of risk for rejections after heart transplantation
|
|
|
1999 |
18 |
1 |
p. 80- 1 p. |
artikel |
111 |
Immunomodulatory effects of donor bone marrow infusion in heart or lung transplantation: Five year experience
|
|
|
1999 |
18 |
1 |
p. 72- 1 p. |
artikel |
112 |
Impact of antibodies to HLA class I molecules on the development of BOS
|
|
|
1999 |
18 |
1 |
p. 51- 1 p. |
artikel |
113 |
Impact of donor brain death on tempo and intensity of acute rejection of rat cardiac allografts
|
Wilhelm, M.J. |
|
1999 |
18 |
1 |
p. 68- 1 p. |
artikel |
114 |
Impact of morphology and ventilatory mechanics upon early functional outcome after lung volume reduction surgery
|
Wisser, W. |
|
1999 |
18 |
1 |
p. 42- 1 p. |
artikel |
115 |
Impact of patient noncompliance on survival in cardiac transplant recipients
|
|
|
1999 |
18 |
1 |
p. 38- 1 p. |
artikel |
116 |
Implantable left ventricular assist devices can successfully bridge pediatric patients to transplant
|
|
|
1999 |
18 |
1 |
p. 89- 1 p. |
artikel |
117 |
Improved prevention of graft arteriosclerosis with thymoglobuline induction therapy in patients after cardiac transplantation
|
|
|
1999 |
18 |
1 |
p. 93-94 2 p. |
artikel |
118 |
Improved results for retransplantation in acute and late pulmonary graft failure
|
|
|
1999 |
18 |
1 |
p. 56- 1 p. |
artikel |
119 |
Increased intragraft expression of TGF-β mRNA in patients with graft vascular disease after clinical heart transplantation
|
|
|
1999 |
18 |
1 |
p. 52- 1 p. |
artikel |
120 |
Increased or de novo expression of ICAM-1, VCAM-1 and E-selectin on cytomegalovirus-infected endothelial and vascular smooth muscle cells is induced by il-1β release
|
|
|
1999 |
18 |
1 |
p. 61- 1 p. |
artikel |
121 |
Index to authors of abstracts
|
|
|
1999 |
18 |
1 |
p. 95-105 11 p. |
artikel |
122 |
Indirect allorecognition of HLA class II allopeptides in lung allograft recipients
|
Reznik, S.I. |
|
1999 |
18 |
1 |
p. 68- 1 p. |
artikel |
123 |
Induction of cardiac allograft endothelial dysfunction by cytokines in humans
|
|
|
1999 |
18 |
1 |
p. 64- 1 p. |
artikel |
124 |
Inflammatory cytokines and hepatic sinusoid endothelial dysfunction play a role in hyperbilirubinemia in patients following implantation of an LVAS
|
|
|
1999 |
18 |
1 |
p. 57- 1 p. |
artikel |
125 |
Influence of HLA matching on survival and development of obliterative bronchiolitis (OB) after lung transplantation
|
|
|
1999 |
18 |
1 |
p. 50-51 2 p. |
artikel |
126 |
Influence of ischemic time on hyperacute xenograft rejection in a working pig heart model with immunoadsorption
|
|
|
1999 |
18 |
1 |
p. 59- 1 p. |
artikel |
127 |
Inhaled nitric oxide in early severe allograft lung dysfunction
|
Planas, A. |
|
1999 |
18 |
1 |
p. 55- 1 p. |
artikel |
128 |
Inhibition of hyperacute pig-to-human xenograft rejection by modulating the fluid-phase complement activation
|
|
|
1999 |
18 |
1 |
p. 66- 1 p. |
artikel |
129 |
Inhibition of throm☐ane A2 and platelet adhesion with salicylic acid effectively ameliorates reperfusion injury following acute double lung transplantation in the rat
|
Hausen, B. |
|
1999 |
18 |
1 |
p. 79-80 2 p. |
artikel |
130 |
Inter-hospital transfer of patients receiving advanced mechanical circulatory support
|
|
|
1999 |
18 |
1 |
p. 90- 1 p. |
artikel |
131 |
International Society for Heart and Lung Transplantation
|
|
|
1999 |
18 |
1 |
p. 1- 1 p. |
artikel |
132 |
International survey of routine surveillance biopsy practices in adult heart transplantation
|
Aaronson, K.D. |
|
1999 |
18 |
1 |
p. 80- 1 p. |
artikel |
133 |
Intraoperative liposome-mediated gene transfection of nitric oxide synthase (ecNOS) reduces ischemia-reperfusion injury in transplanted hearts
|
|
|
1999 |
18 |
1 |
p. 37- 1 p. |
artikel |
134 |
Intravascular ultrasound has prognostic impact after heart transplantation: A multivariable analysis in a large patient cohort
|
|
|
1999 |
18 |
1 |
p. 50- 1 p. |
artikel |
135 |
Intravenous (IV) inotrope and vasodilator therapy in a critical care setting utilizing a heart failure specialty team care approach (HFSTC) with “hemodynamic goal” protocols vs a general cardiology care approach (GCC)
|
|
|
1999 |
18 |
1 |
p. 75- 1 p. |
artikel |
136 |
In-vivo measurement of oxygen free radical production correlates with pulmonary reperfusion injury
|
|
|
1999 |
18 |
1 |
p. 74- 1 p. |
artikel |
137 |
Is it safe to utilize hearts from donors with positive blood cultures?
|
|
|
1999 |
18 |
1 |
p. 79- 1 p. |
artikel |
138 |
Is the use of donor hearts with left ventricular hypertrophy acceptable?
|
|
|
1999 |
18 |
1 |
p. 87- 1 p. |
artikel |
139 |
Is the use of left ventricular assist device as a bridge to heart transplantation a risk factor for development of transplant coronary artery disease?
|
|
|
1999 |
18 |
1 |
p. 63- 1 p. |
artikel |
140 |
IVIG postpones alloimmunization in LVAD and artificial heart recipients
|
|
|
1999 |
18 |
1 |
p. 57- 1 p. |
artikel |
141 |
Late functional outcome after transplantation (Tx) versus norwood 3 stage palliation (Nw) for infants with hypoplastic left heart syndrome (HLHS)
|
|
|
1999 |
18 |
1 |
p. 70- 1 p. |
artikel |
142 |
Late rejection greater than 1 year after pediatric heart transplantation: An ominous finding
|
|
|
1999 |
18 |
1 |
p. 69- 1 p. |
artikel |
143 |
Left ventricular diastolic function after bicaval and standard cardiac transplantation
|
|
|
1999 |
18 |
1 |
p. 44-45 2 p. |
artikel |
144 |
Left ventricular reconstruction using the DOR procedure for ischemic aneurysm or akinetic dilatation
|
Marullo, A.G.M. |
|
1999 |
18 |
1 |
p. 42- 1 p. |
artikel |
145 |
Long-term follow-up of thoratec ventricular assist device bridge-to-recovery patients after resolution of non-ischemic heart failure
|
|
|
1999 |
18 |
1 |
p. 62-63 2 p. |
artikel |
146 |
Long term home discharge support with novacor LVAS
|
|
|
1999 |
18 |
1 |
p. 67-68 2 p. |
artikel |
147 |
Long term physical training in cardiac transplant candidates: Is it feasible?
|
|
|
1999 |
18 |
1 |
p. 75-76 2 p. |
artikel |
148 |
Loss of airway goblet cells is associated with respiratory epithelial injury in a rat model of allograft rejection
|
Wan, B. |
|
1999 |
18 |
1 |
p. 90- 1 p. |
artikel |
149 |
Low cardiac neuronal function and predicted value of maximum oxygen consumption predict for high risk of cardiac events in cardiomyopathy
|
|
|
1999 |
18 |
1 |
p. 47- 1 p. |
artikel |
150 |
Low producers of TGF beta are protected from cardiac transplant vasculopathy
|
|
|
1999 |
18 |
1 |
p. 52- 1 p. |
artikel |
151 |
LPD solution in clinical lung transplantation
|
Stru¨ber, M. |
|
1999 |
18 |
1 |
p. 87- 1 p. |
artikel |
152 |
Maintaining or improving nutritional parameters for patients awaiting lung transplantation
|
Endres, N.L. |
|
1999 |
18 |
1 |
p. 91- 1 p. |
artikel |
153 |
Maximizing thoracic organ transplant (TOTx) opportunities- the importance of efficient co-ordination
|
|
|
1999 |
18 |
1 |
p. 86- 1 p. |
artikel |
154 |
Mechanical unloading restores beta-adrenergic responsiveness in the failing human heart
|
|
|
1999 |
18 |
1 |
p. 63- 1 p. |
artikel |
155 |
Mechanisms of brain death associated myocardial dysfunction
|
|
|
1999 |
18 |
1 |
p. 87- 1 p. |
artikel |
156 |
Mechanisms of coronary artery remodeling in heart transplant recipients. A serial study with intravascular ultrasound and three-dimensional vessel reconstruction
|
|
|
1999 |
18 |
1 |
p. 65- 1 p. |
artikel |
157 |
Medium term results of children with two hearts
|
|
|
1999 |
18 |
1 |
p. 84- 1 p. |
artikel |
158 |
Meeting information
|
|
|
1999 |
18 |
1 |
p. 6-35 30 p. |
artikel |
159 |
Metallothionein is involved in reverse remodelling after prolonged left ventricular assist device support
|
|
|
1999 |
18 |
1 |
p. 57- 1 p. |
artikel |
160 |
Modulation of pulmonary Na+ pump gene expression during cold storage and reperfuson
|
|
|
1999 |
18 |
1 |
p. 74- 1 p. |
artikel |
161 |
MPA-dose adjustment based on trough levels- high and low dose pharmacokinetics in heart transplanted patients
|
Schmidt, D. |
|
1999 |
18 |
1 |
p. 46- 1 p. |
artikel |
162 |
Multicenter, double-blind, randomized study of neoral vs sandimmune in heart transplantation: One year results
|
|
|
1999 |
18 |
1 |
p. 93- 1 p. |
artikel |
163 |
Mycophenolate mofetil for secondary prevention of allograft vasculopathy following heart transplantation: A prospective; randomized; intravascualr ultrasound controlled trial
|
Pethig, K. |
|
1999 |
18 |
1 |
p. 77-78 2 p. |
artikel |
164 |
Mycophenolate mofetil in paediatric heart transplant recipients: A single center experience
|
|
|
1999 |
18 |
1 |
p. 83-84 2 p. |
artikel |
165 |
Mycophenolic acid concentrations are associated with cardiac allograft rejection
|
|
|
1999 |
18 |
1 |
p. 46- 1 p. |
artikel |
166 |
Myocardial HLA and ICAM-1 staining pattern in biopsies from transplanted hearts. Three years follow-up
|
|
|
1999 |
18 |
1 |
p. 40- 1 p. |
artikel |
167 |
Noncompliance causing late acute rejection in pediatric heart transplantation
|
|
|
1999 |
18 |
1 |
p. 70- 1 p. |
artikel |
168 |
Noninvasive cardiac graft monitoring: The graz experience
|
Grasser, B. |
|
1999 |
18 |
1 |
p. 80- 1 p. |
artikel |
169 |
Noninvasive. Cost-effective detection of cardiac allograft vasculopathy by electron beam computed tomography (EBCT)
|
|
|
1999 |
18 |
1 |
p. 49- 1 p. |
artikel |
170 |
Optimal timing of lung transplantation in cystic fibrosis patients
|
|
|
1999 |
18 |
1 |
p. 86- 1 p. |
artikel |
171 |
Outcome of infants listed for lung or heart/lung transplantation
|
|
|
1999 |
18 |
1 |
p. 83- 1 p. |
artikel |
172 |
Outcome of listing for cardiac transplantation for failed fontan: A multi-institutional study
|
|
|
1999 |
18 |
1 |
p. 69- 1 p. |
artikel |
173 |
Outcomes with hepatitis C following cardiac transplantation — a multi-institutional study
|
|
|
1999 |
18 |
1 |
p. 81- 1 p. |
artikel |
174 |
Outpatient inotropic therapy in refractory heart failure
|
Oliva, Fabrizio |
|
1999 |
18 |
1 |
p. 75- 1 p. |
artikel |
175 |
Patient outcome and costs following an acute heart failure (HF) management program in an emergency department (ED) observation unit (OU)
|
|
|
1999 |
18 |
1 |
p. 92- 1 p. |
artikel |
176 |
Pediatric cardiac retransplantation: Experience at a single institution
|
Dearani, J.A. |
|
1999 |
18 |
1 |
p. 70- 1 p. |
artikel |
177 |
Pediatric heart transplant school re-entry
|
Rodgers, S |
|
1999 |
18 |
1 |
p. 58- 1 p. |
artikel |
178 |
Post-transplant lymphoproliferative disease (PTLD) following lung transplantation in Canadian transplant centers
|
|
|
1999 |
18 |
1 |
p. 85- 1 p. |
artikel |
179 |
p21 overexpression inhibits cell proliferation and enhances cyclosporine's antiproliferative effects: A novel strategy for immunosuppression
|
|
|
1999 |
18 |
1 |
p. 49- 1 p. |
artikel |
180 |
Predictors of survival to transplant in cystic fibrosis: Impact of international listing guidelines
|
|
|
1999 |
18 |
1 |
p. 55- 1 p. |
artikel |
181 |
Pressure mediated delivery of decoy NF-κB binding oligodeoxynucleotides decreases reperfusion injury in rodent cardiac allografts
|
|
|
1999 |
18 |
1 |
p. 48- 1 p. |
artikel |
182 |
Pretransplant panel reactive antibodies are associated with increased risk of transplant coronary artery disease (TCAD) in cardiac transplant recipients
|
|
|
1999 |
18 |
1 |
p. 76- 1 p. |
artikel |
183 |
Prevention of chronic rejection by nonselective endothelin receptor antagonist
|
Sihvola, R.K. |
|
1999 |
18 |
1 |
p. 61-62 2 p. |
artikel |
184 |
Prevention of endothelial cell activation in hamster-to-rat cardiac xenografts by gene transfection of BCL-2
|
|
|
1999 |
18 |
1 |
p. 66- 1 p. |
artikel |
185 |
Profile of soluble coagulant and inflammatory markers during long-term left ventricular assist device support
|
|
|
1999 |
18 |
1 |
p. 56-57 2 p. |
artikel |
186 |
Prognostic value of circulating levels of interleukin-6 in patients with congestive heart failure
|
|
|
1999 |
18 |
1 |
p. 91-92 2 p. |
artikel |
187 |
Prognostic value of low versus high dosage of angiotensin converting enzyme inhibitors in patients awaiting heart transplantation
|
|
|
1999 |
18 |
1 |
p. 75- 1 p. |
artikel |
188 |
Prognostic value of the relative lymphocyte concentration and white blood cell count in heart failure
|
|
|
1999 |
18 |
1 |
p. 47- 1 p. |
artikel |
189 |
Program committee
|
|
|
1999 |
18 |
1 |
p. 2- 1 p. |
artikel |
190 |
Prophylactic and preemptive strategies for control of legionnaires' disease in heart transplant recipients. A single center 10-years survey in a high-risk environment
|
|
|
1999 |
18 |
1 |
p. 77- 1 p. |
artikel |
191 |
Prospective randomized two-center trial comparing cyclosporine A (CSA) vs. tacrolimus (TAC), in combination with mycophenolate mofetil (MMF) and steroids after lung transplantation (LTX)
|
|
|
1999 |
18 |
1 |
p. 45-46 2 p. |
artikel |
192 |
Prostacyclin- and throm☐ane-synthases in transplanted human hearts. Relation to coronary endothelial function
|
|
|
1999 |
18 |
1 |
p. 64- 1 p. |
artikel |
193 |
Psychological evaluation as a prognostic factor among patients candidates for cardiac transplantation
|
Moscoloni, S.E. |
|
1999 |
18 |
1 |
p. 58- 1 p. |
artikel |
194 |
Public and professional attitudes toward xenotransplantion and other options to increase organ availability
|
|
|
1999 |
18 |
1 |
p. 92- 1 p. |
artikel |
195 |
Pulmonary volume increases with linear growth in pediatric living donor lobar lung transplant recipients
|
|
|
1999 |
18 |
1 |
p. 86- 1 p. |
artikel |
196 |
RacCA gene transfer supresses the development of aortic allograft arteriosclersosis in the rat
|
|
|
1999 |
18 |
1 |
p. 48- 1 p. |
artikel |
197 |
Randomised trial of blood eosinophil count (EOS) monitoring to guide steroid dose adjustment in the control of heart allograft rejection
|
|
|
1999 |
18 |
1 |
p. 93- 1 p. |
artikel |
198 |
Randomised trial of cardiomyoplasty against optimal medical therapy in class III heart failure
|
|
|
1999 |
18 |
1 |
p. 67- 1 p. |
artikel |
199 |
Recipient weight as an independent risk factor in heart transplantation
|
Mullen, G.M. |
|
1999 |
18 |
1 |
p. 92- 1 p. |
artikel |
200 |
Reductions in type 1 fibre proportions and oxidative enzyme activity in skeletal muscle exist pre & post lung transplantation
|
Morton, J.M. |
|
1999 |
18 |
1 |
p. 52- 1 p. |
artikel |
201 |
Refining the criteria for heart transplant listing and status: A multi-institutional risk factor analysis for rehospitalization following listing
|
|
|
1999 |
18 |
1 |
p. 47- 1 p. |
artikel |
202 |
Regulatory roles of chemokines in delayed cardiac xenograft rejection
|
|
|
1999 |
18 |
1 |
p. 59- 1 p. |
artikel |
203 |
Resting left ventricular size predicts improved native cardiac output during exercise and the ability to exercise with the device weaned in patients with the TCI heartmate left ventricular assist device
|
|
|
1999 |
18 |
1 |
p. 44- 1 p. |
artikel |
204 |
Resting myocardial blood flow and metabolism predicts improved native left ventricular output and the ability to exercise with weaning in patients with the TCI heartmate left ventricular assist device
|
Maybaum, S. |
|
1999 |
18 |
1 |
p. 62- 1 p. |
artikel |
205 |
Results of expandable metal stent placement in lung transplant recipients
|
|
|
1999 |
18 |
1 |
p. 60- 1 p. |
artikel |
206 |
Results of lung transplantation following lung volume reduction surgery
|
Wisser, W. |
|
1999 |
18 |
1 |
p. 67- 1 p. |
artikel |
207 |
Revascularisation for post-ischaemic heart failure: How myocardial viability affects survival
|
Pagano, D. |
|
1999 |
18 |
1 |
p. 67- 1 p. |
artikel |
208 |
Reversal of the heart failure phenotype by mechanical unloading
|
|
|
1999 |
18 |
1 |
p. 89-90 2 p. |
artikel |
209 |
Risk factor analysis for inappropriate growth after pediatric heart transplantation(HTX)
|
|
|
1999 |
18 |
1 |
p. 91- 1 p. |
artikel |
210 |
175 Risk factor analysis for skin cancer in heart transplant (HT) recipients
|
Belloni, A. |
|
1999 |
18 |
1 |
p. 77- 1 p. |
artikel |
211 |
Role of neural and humoral factors in cardiac dysfunction in the potential organ donor
|
|
|
1999 |
18 |
1 |
p. 39- 1 p. |
artikel |
212 |
Selective adenosine-a 2A activation reduces lung reperfusion injury following transplantation
|
|
|
1999 |
18 |
1 |
p. 72- 1 p. |
artikel |
213 |
Sequential evaluation of big endothelin plasma concentration in patients with advanced heart failure: Effects of therapy
|
|
|
1999 |
18 |
1 |
p. 47- 1 p. |
artikel |
214 |
Should advanced recipient age be contraindicated in cardiac transplantation? Continued analysis of a single center experience
|
|
|
1999 |
18 |
1 |
p. 45- 1 p. |
artikel |
215 |
Sirolimus (Rapamycin) blood levels correlate with prevention of graft vascular disease (GVD) in monkey aortic transplants as monitored by intravascular ultrasound
|
|
|
1999 |
18 |
1 |
p. 72- 1 p. |
artikel |
216 |
Soluble rat class I MHC proteins induce prolonged survival of rat cardiac allografts
|
|
|
1999 |
18 |
1 |
p. 68- 1 p. |
artikel |
217 |
Stat4-mediated TH1 responses promote the development ofgraft arteriosclerosis
|
|
|
1999 |
18 |
1 |
p. 71- 1 p. |
artikel |
218 |
Successful cardiac transplantation of pre-sensitized children without a prospective crossmatch: Preliminary results
|
|
|
1999 |
18 |
1 |
p. 83- 1 p. |
artikel |
219 |
Successful lung transplantation with the use of marginal donors
|
|
|
1999 |
18 |
1 |
p. 79- 1 p. |
artikel |
220 |
Survival outcomes of patients with giant cell myocarditis bridged by ventricular assist devices
|
|
|
1999 |
18 |
1 |
p. 43-44 2 p. |
artikel |
221 |
Synergistic effect of endothelin- and PAF antagonists on posttransplant lung ischemia/reperfusion injury
|
Stammberger, U. |
|
1999 |
18 |
1 |
p. 74-75 2 p. |
artikel |
222 |
T cell activation in left ventricular assist device (LVAD) recipients occurs via a CD95-dependent pathway, and results in loss of th1 cells and high levels of circulating IL-10
|
|
|
1999 |
18 |
1 |
p. 56- 1 p. |
artikel |
223 |
T cell apoptosis and defects in cellular immunity induced by exposure to biomaterials: Implications for left ventricular assist device (LVAD) implantation
|
Ankersmit, J |
|
1999 |
18 |
1 |
p. 56- 1 p. |
artikel |
224 |
Temporal pattern of T lymphocyte and macrophage infiltration in a nonimmunosuppressed model of CAV
|
|
|
1999 |
18 |
1 |
p. 40-41 2 p. |
artikel |
225 |
Temporary ECMO support following lung and heart-lung transplantation
|
|
|
1999 |
18 |
1 |
p. 55- 1 p. |
artikel |
226 |
TGF beta polymorphism does not influence the rise in creatinine following cardiac transplantation
|
|
|
1999 |
18 |
1 |
p. 77- 1 p. |
artikel |
227 |
The actions of cyclosporine-A on apoptosis and p53 expression in human vascular smooth muscle cells
|
|
|
1999 |
18 |
1 |
p. 61- 1 p. |
artikel |
228 |
The effect of inhaled steroids on exhaled nitric oxide in lung transplant recipients with lymphocytic bronchitis
|
|
|
1999 |
18 |
1 |
p. 45- 1 p. |
artikel |
229 |
The effect of intra-pulmonary CXC-chemokines in the donor lung on early graft function after lung transplantation
|
Fisher, A.J. |
|
1999 |
18 |
1 |
p. 88- 1 p. |
artikel |
230 |
The effect of pre lung transplant clinical status on post transplant outcome for children with cystic fibrosis: A ten year experience
|
|
|
1999 |
18 |
1 |
p. 83- 1 p. |
artikel |
231 |
The effects of inhaled nitric oxide, gabexate mesilate (FOY), and retrograde perfusion in the lung grafts from non-heart-beating minipig donors
|
|
|
1999 |
18 |
1 |
p. 62- 1 p. |
artikel |
232 |
The immunomodulatory role of simvastatin and pravastatin on cardiac allograft rejection: A prospective randomized trial
|
|
|
1999 |
18 |
1 |
p. 76- 1 p. |
artikel |
233 |
The impact of early myocardial endothelin expression on functional and morphological coronary alterations during follow-up in cardiac transplant recipients
|
|
|
1999 |
18 |
1 |
p. 64- 1 p. |
artikel |
234 |
The impact of explosive brain death on the genesis of cardiac allograft vasculopathy: An intravascular ultrasound study
|
|
|
1999 |
18 |
1 |
p. 49- 1 p. |
artikel |
235 |
The impact of ganciclovir-resistant cytomegalovirus infection in lung transplantation
|
|
|
1999 |
18 |
1 |
p. 82- 1 p. |
artikel |
236 |
The impact of HLA sensitization and donor cause of death in heart transplantation
|
|
|
1999 |
18 |
1 |
p. 38- 1 p. |
artikel |
237 |
The international lung transplant database: Demographics and outcomes in 826 lung transplant recipients
|
|
|
1999 |
18 |
1 |
p. 86- 1 p. |
artikel |
238 |
Therapeutic monitoring of mycophenolic acid (MPA): Assays of immune function in peripheral blood predict efficacy for inhibition of histologic graft rejection
|
Gummert, J.F. |
|
1999 |
18 |
1 |
p. 53-54 2 p. |
artikel |
239 |
The regulatory role of IL-10 in experimental obliterative bronchiolitis (OB)
|
Mulligan, M.S. |
|
1999 |
18 |
1 |
p. 88- 1 p. |
artikel |
240 |
The role of antibodies in dysfunction of pig-to-baboon pulmonary transplants
|
Lau, Christine L. |
|
1999 |
18 |
1 |
p. 65-66 2 p. |
artikel |
241 |
The role of flow cytometry detected IgG and IgM anti-donor antibodies in cardial allograft recipients
|
|
|
1999 |
18 |
1 |
p. 38- 1 p. |
artikel |
242 |
The role of lipids and fibrinogen in coronary vasomotor dysfunction after cardiac transplantation
|
|
|
1999 |
18 |
1 |
p. 50- 1 p. |
artikel |
243 |
The significance of bronchial associated lymphoid tissue in human lung transplantation: Is there an association with acute and chronic rejection?
|
|
|
1999 |
18 |
1 |
p. 41- 1 p. |
artikel |
244 |
Three year results of the double-blind randomized multicenter trial of mycophenolate mofetil in heart transplant patients
|
|
|
1999 |
18 |
1 |
p. 53- 1 p. |
artikel |
245 |
Time course of reverse left ventricular remodeling in response to carvedilol in heart failure
|
|
|
1999 |
18 |
1 |
p. 76- 1 p. |
artikel |
246 |
Transforming growth factor-beta (TGF-B) and allograft vasculopathy following heart transplantation
|
Aziz, T |
|
1999 |
18 |
1 |
p. 37- 1 p. |
artikel |
247 |
Transmyocardial laser revascularisation in class IV angina — A randomised trial
|
|
|
1999 |
18 |
1 |
p. 42- 1 p. |
artikel |
248 |
Transmyocardial laser revascularization (TMR) in ischemic cardiomyopathy
|
Grauhan, O. |
|
1999 |
18 |
1 |
p. 66- 1 p. |
artikel |
249 |
Transplantation of “thymoheart” allografts in miniature swine
|
Menard, M.T. |
|
1999 |
18 |
1 |
p. 71- 1 p. |
artikel |
250 |
Treatment differences and clinical outcomes of advanced heart failure (HF) patients with a critical care admission using specialist team protocols vs. general cardiology care
|
|
|
1999 |
18 |
1 |
p. 76- 1 p. |
artikel |
251 |
Use of daclizumab decreases the frequency of early allograft rejection in de-novo heart transplant recipients
|
|
|
1999 |
18 |
1 |
p. 45- 1 p. |
artikel |
252 |
Use of inhaled nitric oxide in cardiac transplantation
|
|
|
1999 |
18 |
1 |
p. 44- 1 p. |
artikel |
253 |
Use of sequence specific oligodeoxynucleotides to inhibit myointimal proliferation associated with graft coronary artery disease
|
|
|
1999 |
18 |
1 |
p. 49- 1 p. |
artikel |
254 |
Von willebrand deficient swine lungs transplanted into baboons
|
Lau, Christine L. |
|
1999 |
18 |
1 |
p. 65- 1 p. |
artikel |
255 |
VX-497 inhibits IMPDH and is the first rationally synthesized immunosuppressant to prolong allograft survival
|
Gummert, J.F. |
|
1999 |
18 |
1 |
p. 72- 1 p. |
artikel |
256 |
What are the attitudes of potential heart and heart-lung patients to xenotransplantation?
|
|
|
1999 |
18 |
1 |
p. 92- 1 p. |
artikel |
257 |
Xenogeneic antibodies are not necessary for chronic rejection of vascularised xenografts
|
Briffa, Norman P |
|
1999 |
18 |
1 |
p. 66- 1 p. |
artikel |